Three Emmes employees were among the co-authors of the recent report, “Safety and Immunogenicity of SARS-CoV-2 mRNA-1273 Vaccine in Older Adults.” The employees are Jim Albert, lead project manager; Dr. Mat Makowski, senior biostatistician; and Kaitlyn Cross, senior biostatistician.
In its role as the statistical and data collection and coordination center, Emmes managed development of the statistical analysis plan and performed all data analysis.
{iframe}https://www.biospace.com/article/releases/emmes-employees-co-author-covid-19-vaccine-report-for-the-new-england-journal-of-medicine/{/iframe}